Skip to main content
Category

BioTalk with Rich Bendis Podcast

BioTalk – Betting Big on Innovation in the Desert with BioHealth Las Vegas

By BioTalk with Rich Bendis Podcast, News

In this episode of BioTalk, Rich Bendis sits down with Councilman Brian Knudsen, Jamie Schwartz of UNLV, and Vance Farrow from the Nevada Governor’s Office of Economic Development to spotlight the rapid emergence of Southern Nevada as a rising force in the biohealth landscape. The conversation covers the launch of the $10 million BioHealth Innovation Challenge, the Desert Forge Venture Fund, and the revitalization of BioTech Vegas, all designed to attract industry anchors, fuel early-stage startups, and cultivate a thriving innovation ecosystem. They also explore how strong collaboration between local and state government, academic institutions, and entrepreneurs is propelling Las Vegas into a new era of health innovation, with a focus on brain health, sports science, and workforce development.

Listen now via your favorite podcast platform:
Apple: https://apple.co/3J7ErgK
Spotify: https://bit.ly/3JtB3N4
iHeart: https://ihr.fm/3LvvnCQ
Amazon: https://amzn.to/4ntAy3M
YouTube Music: https://bit.ly/496DEav
TuneIn: https://bit.ly/431mJ5f

Editing and post-production work for this episode was provided by The Podcast Consultant: thepodcastconsultant.com 

Councilman Brian Knudsen was elected to represent Ward 1 in 2019 and re-elected in 2024, continuing his long-standing commitment to public service and community-building in Las Vegas. On December 21, 2022, he was named Mayor Pro Tem. Brian has been instrumental in driving the transformation of the Las Vegas Medical District and expanding public health infrastructure throughout the city. He serves on several boards, including the Southern Nevada Health District and the Regional Transportation Commission, and is a vocal advocate for policies that strengthen healthcare, public safety, and inclusive economic development.

Jamie Schwartz, MBA, is Director of Industry Engagement at the University of Nevada, Las Vegas (UNLV) Office of Economic Development and President of the Board for BioTech Vegas. With deep experience in public-private partnerships and academic-industry collaboration, she works at the intersection of research, innovation, and commercialization to strengthen Southern Nevada’s biotech and health innovation landscape.

Vance Farrow serves as the Healthcare Industry Specialist for the Nevada Governor’s Office of Economic Development. His work focuses on attracting and expanding healthcare businesses throughout the state, aligning talent development efforts, and building the infrastructure needed to support a robust biohealth sector. He plays a critical role in shaping state policy and investment strategies for the industry.

Maryland’s Economic Vision for BioHealth with Commerce Secretary Harry Coker, Jr. on BioTalk

By BioTalk with Rich Bendis Podcast, News

In this episode of BioTalk with Rich Bendis, Harry Coker, Jr., Secretary of the Maryland Department of Commerce, joins the podcast to discuss Maryland’s rising momentum as a global biohealth and technology leader. Secretary Coker shares his unique journey from the CIA, NSA, and White House to leading Maryland’s economic development strategy, highlighting the state’s strengths in life sciences, its appeal to global investors, and the importance of public-private partnerships in accelerating innovation.

Topics include Maryland’s recent recognition as a Top 3 biopharma hub, the decision to prioritize Life Sciences and Computational Biology as “Lifehouse” sectors, and how the state is leveraging the BioHealth Capital Region identity to unite and expand its regional leadership. He also outlines Maryland’s case for investment and why collaboration will be central to “Winning the Decade.”

Listen on your favorite podcast platforms:

Apple: https://apple.co/4mXS5AJ
Spotify: https://bit.ly/3KP44mQ
iHeart: https://ihr.fm/4n1vkvE
Amazon: https://amzn.to/4mYdwl9
YouTube: https://bit.ly/4nm66Zr
TuneIn: https://bit.ly/46R60DW

Editing and post-production work for this episode was provided by The Podcast Consultant.

The Honorable Harry Coker, Jr. was appointed by Governor Wes Moore as Maryland’s Secretary of Commerce in 2025. He is a retired senior executive from the CIA and NSA, former National Cyber Director at the White House, and a career Naval Officer. Coker’s leadership is shaped by decades of public service at the highest levels of national security and technology. At the Maryland Department of Commerce, he leads efforts to build an equitable, competitive economy centered around innovation, inclusion, and impact.

Building Maryland’s BioHealth Future: Maryland Commerce’s Stefanie Trop on Growing the Life Sciences Sector

By BioTalk with Rich Bendis Podcast, News


In this episode of BioTalk with Rich Bendis, Stefanie Trop, Ph.D., Director of Life Sciences at the Maryland Department of Commerce joins the conversation to discuss Maryland’s position as a leading life sciences hub. Stefanie shares how the Department of Commerce supports company attraction and growth through programs like Global Gateway, and how it’s amplifying the state’s recent #3 biopharma hub ranking. The discussion also explores Maryland’s unique ecosystem, including the work of the Governor’s Life Sciences Advisory Board, the state’s leadership in computational health, and the importance of industry collaboration during BioHealth Capital Region Week.

Listen now on your favorite podcast platform:
Apple: https://apple.co/4oHp9Po
Spotify: https://bit.ly/4fEIooK
iHeart: https://ihr.fm/4fGY3UL
Amazon Podcasts: https://amzn.to/47Awvya
YouTube Podcasts: https://bit.ly/3V7rJAI

Editing and post-production work for this episode was provided by The Podcast Consultant.

Dr. Stefanie Trop brings a unique blend of hands-on scientific expertise and high-level strategic insight. With a Ph.D. in Molecular Microbiology and Immunology, she has worked at the ground level in immunology, clinical trials, and vaccine development, while also driving growth through scientific partnerships and business development. Her deep understanding of the science and passion for problem solving guides her ability to build effective collaborations that advance both innovation and commercial success.

At the Maryland Department of Commerce, Stefanie works to connect Maryland’s life sciences companies with national and global resources, expanding the industry’s impact at home and globally. In current and prior roles, she bridges communication gaps between scientific and business teams, ensuring that customer needs translate into innovative products and business wins.

Inside FNIH: Dr. Stacey Adam on Smarter, Human-Based Research on BioTalk

By BioTalk with Rich Bendis Podcast, News

In this episode of BioTalk, Rich Bendis welcomes Dr. Stacey Adam, Vice President of Science Partnerships, Translational Science at the Foundation for the National Institutes of Health (FNIH), to discuss how public-private partnerships are advancing scientific innovation. Dr. Adam introduces the mission of FNIH and its unique role in bridging government, industry, and academia to accelerate biomedical progress. She highlights the Validation and Qualification Network (VQN), a new initiative working to overcome barriers to the adoption of New Approach Methodologies (NAMs) and explains how cross-sector collaboration is driving its early success. The conversation explores the long-term vision of the VQN, the global perspectives shaping its approach, and how it fits into the broader NIH Complement-ARIE initiative. Dr. Adam also reflects on the significance of being headquartered in the BioHealth Capital Region and how it supports the Foundation’s mission.

Listen now via your favorite podcast platform:
Apple – https://apple.co/3UngVhK
Spotify – https://bit.ly/411Mdym
YouTube Podcasts – https://bit.ly/4m3tY3Y
iHeart – https://ihr.fm/4locw9o
Amazon Podcast – https://amzn.to/3JaSO3l

Editing and post-production work for this episode was provided by The Podcast Consultant.

Guest Bio
Dr. Stacey Adam is Vice President of Science Partnerships at the Foundation for the NIH (FNIH), where she leads major public-private partnerships including the RECOVER-Treating Long COVID initiative, multiple Biomarkers Consortium projects, the Accelerating Medicines Partnerships (AMPs), and the Lung-MAP clinical trial. She also leads efforts to design new public-private partnerships focused on pediatric medical devices, cancer systems biology, and the advancement of New Approach Methodologies (NAMs) through the Validation and Qualification Network. Previously, Dr. Adam worked at Deloitte Consulting and completed a postdoctoral fellowship at Stanford University School of Medicine. She holds a PhD in Pharmacology with a Certificate in Mammalian Toxicology from Duke University.

BioBytes Episode 34: How to Launch a Biotech Startup in 2025 | Real Talk with Richard Bendis

By BioTalk with Rich Bendis Podcast, News, News Archive

TSG 34 Richard Bendis YT Thumbnail 400x225Getting a biotech company off the ground takes more than science; it takes strategy, funding, and the right network. 

In this episode, I’m joined by Richard Bendis, Founder, President, and CEO of BioHealth Innovation, Inc., a nonprofit that helps early-stage life sciences companies bridge the gap between great research and commercialization. 

https://www.youtube.com/watch?v=PADCG0qLA8I 

We talk about what it really takes to build a biotech company today, from non-dilutive funding and EIR programs to spinouts and government partnerships. Rich brings a rare perspective from both public and private sides of the ecosystem, with decades of experience in investment, tech transfer, and innovation policy. 

Read More

Reimagining Gene and Cell Therapy: Helen Sabzevari on Precigen’s Breakthroughs in Precision Medicine on BioTalk

By BioTalk with Rich Bendis Podcast, News, News Archive

Helen Sabzevari and Rich TallIn this episode of BioTalk, Rich Bendis welcomes Dr. Helen Sabzevari, President and CEO of Precigen, to discuss the company’s cutting-edge science in gene and cell therapy. Dr. Sabzevari shares how Precigen’s unique AdenoVerse® platform has powered the development of PRGN-2012, a potential first-in-class therapeutic currently under FDA priority review for the treatment of adults with recurrent respiratory papillomatosis (RRP), a rare and devastating disease. She also highlights advances across Precigen’s broader pipeline in immuno-oncology and autoimmune disease and reflects on how Maryland’s BioHealth Capital Region has supported the company’s innovation and growth.

Listen now on your favorite podcast platform:
Apple: https://apple.co/3IdIAPi
Spotify: https://bit.ly/4eKJIGo
iHeart: https://ihr.fm/4krFxAy
YouTube: https://bit.ly/4lnRUPq
Amazon Music: https://amzn.to/4nG3Tt6 
TuneIn: https://bit.ly/4lqEaTG

Editing and post-production work for this episode was provided by The Podcast Consultant.

Read More
Lara Mangravite and Rich Tall

Decentralizing Discovery: Lara Mangravite and the Mission of Digitalis Commons on BioTalk

By BioTalk with Rich Bendis Podcast, News, News Archive

Lara Mangravite and Rich TallIn this episode of BioTalk, Lara Mangravite, PhD, Executive Director of Digitalis Commons, joins the conversation to explore how scientific research is shifting in the U.S., from centralized, institutional models to a more decentralized, innovation-driven landscape. She shares the mission of Digitalis Commons and explains how the organization is working at the intersection of technology, research, and public good to address systemic barriers in health and healthcare. Drawing from her recent article, “Notes on Catalyzing Health,” Lara discusses the growing role of independent research institutions, the challenges of fragmentation, and why this moment calls for new leadership models and public-interest partnerships that can drive coordinated, high-impact solutions.

Listen now on your favorite podcast platform:
Apple: https://apple.co/4jXJdK0
Spotify: https://spoti.fi/4jWAdVm
iHeart: https://ihr.fm/3G800vX
Amazon: https://amzn.to/3SZGR2g
YouTube: https://bit.ly/4k2hF6h
TuneIn: https://bit.ly/445al3F

Read More
Rich and Amy Hay Tall

Inside CTMC: Amy Hay on Reshaping Cell and Gene Therapy on BioTalk

By BioTalk with Rich Bendis Podcast, News

Rich and Amy Hay TallIn this episode of BioTalk, Amy C. Hay, Chief Business and Strategy Officer at the Cell Therapy Manufacturing Center (CTMC), joins the conversation to explore the evolving landscape of cell and gene therapy. Amy shares insights from her extensive career in oncology care and innovation, highlighting the role CTMC—a joint venture between National Resilience and MD Anderson Cancer Center—is playing in accelerating the transition from discovery to commercialization. She discusses the current state of the industry, what disruption really means in this context, and how new business models can drive stability and impact for early-stage biotech companies. Amy also offers her perspective on how manufacturing must evolve to meet clinical demand, and how CTMC is positioned to lead in this next era of therapeutic development.

Listen now via your favorite podcast platform:
Apple: https://apple.co/44dfCYa
Spotify: https://spoti.fi/45SJ3Qv
iHeart: https://ihr.fm/4k7Ck9b
YouTube: https://bit.ly/4jYZ23e
Amazon: https://amzn.to/4k7CoFX
TuneIn: https://bit.ly/3HyBF2X 

Read More
Rich and Sam Tall

Decoding Federal Dollars: Grant Engine CEO Sam Tetlow on the Evolving Biohealth Funding Map on BioTalk

By BioTalk with Rich Bendis Podcast, News

Rich and Sam TallIn this episode of BioTalk, Sam Tetlow, Founder and CEO of Grant Engine, joins the conversation to share insights on how early-stage biotech and life science companies can navigate today’s complex federal funding environment. With a career spanning entrepreneurship, investment, and grant strategy, Sam breaks down what’s changed under the current administration, how companies should position themselves for success, and the durable tactics that still matter in securing SBIRs, ARPA-H contracts, and other non-dilutive awards. He also discusses the evolving priorities at HHS, the role of program officers, and how Grant Engine is adapting to help clients align with shifting agency goals. This episode builds on the upcoming June 10th, 2025 webinar co-hosted by Sam and BioHealth Innovation’s Rich Bendis, “Turning Uncertainty to Opportunity: Mastering Government Funding in 2025.” Learn more and register at: https://info.grantengine.com/turning-uncertainty-into-opportunity-mastering-government-funding-in-2025

Listen via your favorite podcast platform:
Apple – https://apple.co/4jEWGWO
Spotify – https://spoti.fi/3HIa5Qx
iHeart – https://ihr.fm/4dWwB4y
Amazon – https://amzn.to/4jELdqn
YouTube – https://bit.ly/3HHIwqA
TuneIn –  https://bit.ly/2M60Wmx

Read More
Rich and Rick Tall

Banking with Heart: Rick Wieczorek on Financial Solutions for the Biohealth Community on BioTalk

By BioTalk with Rich Bendis Podcast, News

Rich and Rick TallIn this episode of BioTalk, we welcome Rick Wieczorek, President and CEO of the NIH Federal Credit Union (NIHFCU), to discuss how credit unions like NIHFCU are uniquely positioned to support the biohealth and healthcare communities. With over 40 years of industry experience, Rick shares his journey from teller to CEO and reflects on NIHFCU’s 85-year history, its mission-driven approach to service, and the importance of tailoring financial solutions to meet the needs of life science professionals. He also explains the benefits of membership, the value of the NIHFCU “At Work” program for employers, and how the credit union’s “Banking with Heart” philosophy is making a difference across the BioHealth Capital Region.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.